Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 24356-66-9, Fa2dm6879k, Ci 673, Vidarabine (usan), (2r,3s,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol hydrate, Vidarabine [usan]
Molecular Formula
C10H15N5O5
Molecular Weight
285.26  g/mol
InChI Key
ZTHWFVSEMLMLKT-CAMOTBBTSA-N
FDA UNII
FA2DM6879K

A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate
2.1.2 InChI
InChI=1S/C10H13N5O4.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H2/t4-,6-,7+,10-;/m1./s1
2.1.3 InChI Key
ZTHWFVSEMLMLKT-CAMOTBBTSA-N
2.1.4 Canonical SMILES
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.O
2.1.5 Isomeric SMILES
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N.O
2.2 Other Identifiers
2.2.1 UNII
FA2DM6879K
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 9 Beta Arabinofuranosyladenine

2. 9 Beta D Arabinofuranosyladenine

3. 9-beta-arabinofuranosyladenine

4. 9-beta-d-arabinofuranosyladenine

5. Adenine Arabinoside

6. Alpha Ara A

7. Alpha D Arabinofuranosyladenine

8. Alpha-ara A

9. Alpha-d-arabinofuranosyladenine

10. Ara A

11. Ara-a

12. Arabinofuranosyladenine

13. Arabinoside, Adenine

14. Arabinosyladenine

15. Beta Ara A

16. Beta-ara A

17. Vidarabine

18. Vira A

19. Vira-a

20. Viraa

2.3.2 Depositor-Supplied Synonyms

1. 24356-66-9

2. Fa2dm6879k

3. Ci 673

4. Vidarabine (usan)

5. (2r,3s,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Hydrate

6. Vidarabine [usan]

7. (2r,3s,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate

8. Vidarabine [jan]

9. Vidarabine (monohydrate)

10. (2r,3s,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol Hydrate

11. Adenine Arabinofuranoside Hydrate

12. 9-beta-d-arabinofuranosyl-9h-purine-6-amine Monohydrate

13. Drg-0058

14. Unii-fa2dm6879k

15. 9-beta-d-arabinofuranosyladenine Monohydrate

16. Vidarabineh2o

17. Vidarabine H2o

18. Adenine, 9-beta-d-arabinofuranosyl-, Monohydrate

19. Vidarabine [usan:usp:inn:ban:jan]

20. 9h-purin-6-amine, 9-beta-d-arabinofuranosyl-, Monohydrate

21. Vira-a (tn)

22. Vidarabine [vandf]

23. Schembl2929

24. Vidarabine [mart.]

25. Chebi:9978

26. Vidarabine [orange Book]

27. Dtxsid10947210

28. Vidarabine [usp Impurity]

29. 9h-purin-6-amine, 9-.beta.-d-arabinofuranosyl-, Monohydrate

30. Vidarabine Monohydrate [mi]

31. Hy-n6666

32. Mfcd00150980

33. S5297

34. Akos025312428

35. Ccg-267319

36. Nsc 757383

37. Cs-0083211

38. 9-beta-d-arabino Furanosyl Adenine Monohydrate

39. Adenine 9-beta-d-arabinofuranoside Monohydrate

40. C07195

41. D00406

42. T72143

43. Vidarabine (200 Mg)g-2939ug/mg(ai)

44. 9-pentofuranosyl-9h-purin-6-amine--water (1/1)

45. J-015462

46. 9-.beta.-d-arabinofuranosyladenine Monohydrate

47. 9h-purin-6-amine,9-b-d-arabinofuranosyl-,hydrate(1:1)

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 285.26 g/mol
Molecular Formula C10H15N5O5
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count9
Rotatable Bond Count2
Exact Mass285.10731860 g/mol
Monoisotopic Mass285.10731860 g/mol
Topological Polar Surface Area141 Ų
Heavy Atom Count20
Formal Charge0
Complexity335
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antimetabolites

Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)


Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)